A Phase I trial of the sulfonylhydrazine alkylator, VNP40101M (101M), administered weekly in patients (pts) with metastatic cancer
Murren J, Gerson S, Kummar S, Davies M, Remick S, Chu E, Karsten V, Sznol M. A Phase I trial of the sulfonylhydrazine alkylator, VNP40101M (101M), administered weekly in patients (pts) with metastatic cancer. Journal Of Clinical Oncology 2004, 22: 2060-2060. DOI: 10.1200/jco.2004.22.14_suppl.2060.Peer-Reviewed Original ResearchA Phase I trial of the sulfonylhydrazine alkylator, VNP40101M (101M), administered weekly in patients (pts) with metastatic cancer
Murren J, Gerson S, Kummar S, Davies M, Remick S, Chu E, Karsten V, Sznol M. A Phase I trial of the sulfonylhydrazine alkylator, VNP40101M (101M), administered weekly in patients (pts) with metastatic cancer. Journal Of Clinical Oncology 2004, 22: 2060-2060. DOI: 10.1200/jco.2004.22.90140.2060.Peer-Reviewed Original Research